Non-opioid Pain Patches Market

Market Overview

Non-opioid pain patches market expected to register significant growth over the forecast period as increasing demand for non- opioid drugs for pain management. Opioid drugs are commonly prescribed for the treatment of pain and related disorders which resulting in dependency of opioid in the majority of patients.

Rising opioid addiction has encouraged to move towards alternative therapies or non-opioid based treatment. Nowadays, Healthcare professionals are inclining towards non-opioid based therapy or drugs as higher awareness among them related to the opioid dependency. Therefore, Non-opioid pain patches expected to gain greater adoption over the opioid patches as the benefits of reduction in opioid addiction.

Growing chronic and acute pain related disorders are driving the growth of the global non-opioid pain patches market. Increasing prevalence of arthritis and post-herpetic neuralgia favor the growth of the global non-opioid pain patches market. According to the Centers for Disease Control and Prevention (CDC), around 15 million people in the United States reported severe joint pain related to arthritis.

The increasing number of sport related injuries, growing number of accident related injuries expected to propel the demand for non-opioid pain patches for pain management. Non-opioid pain patches are also gaining significant demand for surgical pain management as a growing number of surgical procedures globally. Growing demand non-opioid pain patches to reduce addiction related to opioid is a major factor which upsurges the growth of the global non-opioid pain patches market.

Market Segmentation

Based on product type	Lidocaine Patches Diclofenac Patches Methyl Salicylate Patches Capsaicin Patches Ketoprofen Patches Others
Based on indication	Post-herpetic Neuralgia Arthritis Fibromyalgia Muscle Strain & Sprains Migraines & Headaches Back Pain Others
Based on distribution channel	Hospitals Drug Stores Retail Pharmacies Online Pharmacies

Key Players

Some of the key payers of the non-opioid pain patches market are Pfizer Inc., Teikoku Seiyaku Co. Ltd., GlaxoSmithKline plc., Allergan Plc., Acorda Therapeutics, Inc., Mylan N.V., IBSA Institut Biochimique SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals, Inc., Hisamitsu Pharmaceutical Co., Inc., Teh Seng Pharmaceutical Mfg. Co., Ltd, Hisamitsu Pharmaceutical Co., Inc., Alkermes plc. and others. Non-opioid pain patches market is a highly fragmented market. Various companies are focusing on the development of the non-opioid pain patches for pain management.

The report on Non-opioid Pain Patches Market covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Historical Actual Market Size, 2014 - 2018
• Market Size & Forecast 2019 to 2029
• Supply & Demand Value Chain
• Market Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain
• Market Drivers and Restraints

Regional analysis for Non-opioid Pain Patches Market includes:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

 Report on Non-opioid Pain Patches Market Highlights:

• Shifting industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size
• Recent industry trends
• Key competition landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

To know more about delivery timeline for this report Contact Sales